These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38076321)

  • 1. Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019.
    Zhang C; Fu X; Liu Y; Zhao H; Wang G
    Lancet Reg Health West Pac; 2024 Feb; 43():100972. PubMed ID: 38076321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Reg Health Am; 2023 Sep; 25():100561. PubMed ID: 37727594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Antimicrobial Resistance Collaborators
    Lancet; 2022 Dec; 400(10369):2221-2248. PubMed ID: 36423648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
    European Antimicrobial Resistance Collaborators
    Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of antibiotic resistance in Italy and Western Europe in 2019: a MICROBE-based comparative analysis.
    Zamagni G; Forni S; Iavicoli I; Guicciardi S; Buonsenso D; Ferrara P; De Luca M; Golinelli D; Sanmarchi F; Collatuzzo G; Gemmi F; Naghavi M; Sabbatucci M; Monasta L
    Epidemiol Prev; 2024; 48(1):48-59. PubMed ID: 38482785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of bacterial antimicrobial resistance in Croatia in 2019: a country-level systematic analysis.
    Meštrović T; Ikuta KS; Swetschinski L; Gray A; Robles Aguilar G; Han C; Wool E; Gershberg Hayoon A; Murray CJ; Naghavi M
    Croat Med J; 2023 Aug; 64(4):272-283. PubMed ID: 37654039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
    Kim C; Holm M; Frost I; Hasso-Agopsowicz M; Abbas K
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37414432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global and Regional Burden of Bacterial Antimicrobial Resistance in Urinary Tract Infections in 2019.
    Li X; Fan H; Zi H; Hu H; Li B; Huang J; Luo P; Zeng X
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia.
    Wozniak TM; Dyda A; Merlo G; Hall L
    Lancet Reg Health West Pac; 2022 Oct; 27():100521. PubMed ID: 35832237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 LRI Collaborators
    Lancet Infect Dis; 2017 Nov; 17(11):1133-1161. PubMed ID: 28843578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: A population-level study, Japan, 2015-2018.
    Tsuzuki S; Matsunaga N; Yahara K; Shibayama K; Sugai M; Ohmagari N
    Int J Infect Dis; 2021 Jul; 108():119-124. PubMed ID: 33992765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan.
    Tsuzuki S; Koizumi R; Matsunaga N; Ohmagari N
    Infect Dis Ther; 2023 Jul; 12(7):1823-1834. PubMed ID: 37318709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD Diarrhoeal Diseases Collaborators
    Lancet Infect Dis; 2017 Sep; 17(9):909-948. PubMed ID: 28579426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.
    Cassini A; Högberg LD; Plachouras D; Quattrocchi A; Hoxha A; Simonsen GS; Colomb-Cotinat M; Kretzschmar ME; Devleesschauwer B; Cecchini M; Ouakrim DA; Oliveira TC; Struelens MJ; Suetens C; Monnet DL;
    Lancet Infect Dis; 2019 Jan; 19(1):56-66. PubMed ID: 30409683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of cardiovascular disease attributable to dietary risk factors in the provinces of China, 2002-2018: a nationwide population-based study.
    Fang Y; Xia J; Lian Y; Zhang M; Kang Y; Zhao Z; Wang L; Yin P; Wang Z; Ye C; Zhou M; He Y
    Lancet Reg Health West Pac; 2023 Aug; 37():100784. PubMed ID: 37693878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
    Yang S; Xu H; Sun J; Sun S
    Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.